Lombard Odier Asset Management (Europe)’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-118,000
Closed -$550K 280
2022
Q4
$550K Buy
118,000
+33,000
+39% +$163K 0.02% 256
2022
Q3
$397K Buy
85,000
+35,000
+70% +$221K 0.02% 248
2022
Q2
$296K Buy
+50,000
New +$557K 0.01% 250

Other funds holding GDRX

Lombard Odier Asset Management (Europe)'s GDRX Position: Q1 2023 in Review

Lombard Odier Asset Management (Europe) sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 118,000 shares — an estimated $550K sold.

Lombard Odier Asset Management (Europe) first reported a position in GDRX in Q2 2022 and held it in 3 quarters. The position peaked at $550K in Q4 2022. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 118,000 GoodRx Holdings shares in Q1 2023, an estimated $550K.
  • Lombard Odier Asset Management (Europe) first reported a position in GoodRx Holdings in Q2 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Europe)'s GoodRx Holdings position peaked at $550K in Q4 2022.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2023, filed 15 May 2023.